Skip to main content
SpringerLink
Log in

Drug-Eluting Stents (DES) for Infrapopliteal Interventions

  • Chapter
  • First Online:
Endovascular Interventions

  • 302 Accesses

Abstract

When treating critical limb ischemia (CLI), the primary objective is to increase oxygen delivery to a level commensurate with wound healing and relief of ischemic pain. The most direct way of achieving this goal is to maximize and then sustain conduit flow to the jeopardized angiosome. The hallmark of CLI is the presence of severe below-the-knee (BTK) arterial disease, yet for more than 40 years, the guiding principle of surgical limb salvage has been the establishment of single-vessel, straight-line pulsatile flow to the foot. However, this construct evolved from the surgical limitation of not being able to bypass more than one artery. In contradistinction, modern endovascular techniques afford the potential of delivering a more complete arterial revascularization thus improved limb salvage. In this chapter, we will focus on the use of balloon-expandable coronary drug-eluting stents (DES) which, in this author’s opinion, is the safest, most expedient, and most effective method of establishing and maintaining BTK artery patency.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Graziani L, Silvestro A, Bertone V, Manara E, Andreini R, Sigala A, Mingardi R, De Giglio R. Vascular involvement in diabetic subjects with ischemic foot ulcer: a new morphologic categorization of disease severity. Eur J Endovasc Surg. 2007;(4):453–60.

    Article  Google Scholar 

  2. Parsons RE, Suggs WD, Lee JJ, Luis A, Sanchez LA, Lyon RT, et al. Percutaneous transluminal angioplasty for the treatment of limb threatening ischemia: do the results justify an attempt before bypass grafting? J Vasc Surg. 1998;28:1066.

    Article  PubMed  CAS  Google Scholar 

  3. Giles K, Pomposelli FB, Hamdan A, Blattman SB, Panossian H, Schermerhorn ML. Infrapopliteal angioplasty for critical limb ischemia: relation of transatlantic intersociety consensus class to outcomes in 176 limbs. J Vasc Surg. 2008;48:128–36.

    Article  PubMed  Google Scholar 

  4. Schmidt A, Ulrich M, Winkler B, Klaeffling C, Bausback Y, Bra¨unlich S, et al. Angiographic patency and clinical outcome after balloon-angioplasty for extensive infrapopliteal arterial disease. Catheter Cardiovasc Interv. 2010;76:1047–54.

    Article  PubMed  Google Scholar 

  5. Schmidt A, Piorkowski M, Werner M, Ulrich M, Bausback Y, Bräunlich S, et al. First experience with drug-eluting balloons in infrapopliteal arteries: restenosis rates and clinical outcome. J Am Coll Cardiol. 2011;58(11):1105–9.

    Article  PubMed  CAS  Google Scholar 

  6. Adam DJ, Beard JD, Cleveland T, Bell J, Bradbury AW, Forbes JF, et al. BASIL trial participants. Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multi-centre randomised controlled trial. Lancet. 2005;366:1925–34.

    Article  PubMed  CAS  Google Scholar 

  7. Bradbury AW, Adam DJ, Bell J, Forbes JF, Golkes FR, Billespie I, et al. Bypass versus angioplasty in severe ischaemia of the leg (BASIL) trial: an intention-to-treat analysis of amputation-free and overall survival in patients randomized to a bypass surgery-first or a balloon angioplasty-first revascularization strategy. J Vasc Surg. 2010;51:5s–17s.

    Article  PubMed  Google Scholar 

  8. Bittl JA, Chew DP, Topol EJ, Kong DF, Califf RM. Meta-analysis of randomized trials of percutaneous transluminal coronary angioplasty versus atherectomy, cutting balloon atherectomy, or laser angioplasty. J Am Coll Cardiol. 2004;43:936–42.

    Article  PubMed  Google Scholar 

  9. Dorros G, Hall P, Prince C. Successful limb salvage after recanalization of an occluded infrapopliteal artery utilizing a balloon expandable (Palmaz-Schatz) stent. Cathet Cardiovasc Diagn. 1993;28:83–8.

    Article  PubMed  CAS  Google Scholar 

  10. Feiring AJ, Wesolowski AA, Lade S. Primary stent-supported angioplasty for treatment of below-knee critical limb ischemia and severe claudication. Early and one-year outcomes. J Am Coll Cardiol. 2004;44:2307–14.

    Article  PubMed  Google Scholar 

  11. Rastan A, Schwarzwalder U, Noory E, Taieb FH, Beschorner U, Sixt S, et al. Primary use of sirolimus-eluting stents in the infrapopliteal arteries. J Endovasc Ther. 2010;17:480–7.

    Article  PubMed  Google Scholar 

  12. Siablis D, Karnabatidis D, Katsanos K, Kagadis GC, Kraniotis P, Diamantopoulous A, et al. Sirolimus-eluting versus bare stents after suboptimal infrapopliteal angioplasty for critical limb ischemia: enduring 1-year angiographic and clinical benefit. J Endovasc Ther. 2007;14:241–50.

    Article  PubMed  Google Scholar 

  13. Siablis D, Kranioti P, Karnabatidis D, Kagadis GC, Katsanos K, Tsolakis J. Sirolimus-eluting versus bare stents for bailout after suboptimal infrapopliteal angioplasty for critical limb ischemia: 6-month angiographic results from a nonrandomized prospective single-center study. J Endovasc Ther. 2005;12:685–95.

    Article  PubMed  Google Scholar 

  14. Scheinert D, Ulrich M, Scheinert S, Sax J, Braunlick S, Biamino G, et al. Comparison of sirolimus drug-eluting vs. bare metal stents for the treatment of infrapopliteal obstructions. EuroIntervention. 2006;2:169–74.

    PubMed  Google Scholar 

  15. Balzer JO, Zeller T, Rastan A, Sixt S, Vogl TJ, Lehnert T, et al. Percutaneous interventions below the knee in patients with critical limb ischemia using drug-eluting stents. J Cardiovasc Surg (Torino). 2010;51(2):183–91.

    CAS  Google Scholar 

  16. Bosiers M, Deloose K, Verbist J, Peeters P. Percutaneous transluminal angioplasty for treatment of “below-the-knee” critical limb ischemia: early outcomes following the use of sirolimus-eluting stents. J Cardiovasc Surg. 2006;47:171–6.

    CAS  Google Scholar 

  17. Commeau P, Barragan P, Roquebert PO. Sirolimus for below the knee lesions: mid-term results of SiroBTK study. Catheter Cardiovasc Interv. 2006;68:793–8.

    Article  PubMed  Google Scholar 

  18. Feiring AJ, Krahn M, Nelson L, Wesolowski A, Eastwood D, Szabo A. Preventing leg amputations in critical limb ischemia with below-the-knee drug-eluting stents. The PaRADISE (Preventing Amputations using Drug-eluting StEnts Trial). J Am Coll Cardiol. 2010;55:1580–9.

    Article  PubMed  Google Scholar 

  19. Feiring AJ, Wesolowski AA. Antegrade popliteal artery approach for the treatment of critical limb ischemia in patients with occluded superficial femoral arteries. Catheter Cardiovasc Interv. 2007;69:665–70.

    Article  PubMed  Google Scholar 

  20. Grant AG, White CJ, Collins TJ, Jenkins JS, Reilly JP, Ramee SR. Infrapopliteal drug-eluting stents for chronic limb ischemia. Catheter Cardiovasc Interv. 2007;71(1):108–11.

    Article  Google Scholar 

  21. Karnabatidis D, Spillopoulous S, Diamantopoulos A, Katsanos K, Kagadis G, Stavros K, et al. Primary everolimus-eluting stenting versus balloon angioplasty with bailout bare metal stenting of long infrapopliteal lesions for treatment of critical limb ischemia. J Endovasc Ther. 2011;18:1–12.

    Article  PubMed  Google Scholar 

  22. Fischman AM, Shah SS, Kim E, Stangl P, Nowakowski F, Weintraub JL, Lookstein R. Single-center experience with drug-eluting stents for infrapopliteal occlusive disease in patients with critical limb ischemia. SIR. 2010; Abstract 208.

    Google Scholar 

  23. Rosales OR, Mathewkutty S, Gnaim C. Drug-eluting stents for below the knee lesions in patients with critical limb ischemia: long-term follow-up. Catheter Cardiovasc Interv. 2008;72:112–5.

    PubMed  Google Scholar 

  24. Siablis D, Karnabatidis D, Katsanos K, Diamantopoulous A, Christeas N, Kagadis G. Infrapopliteal application of paclitaxel-eluting stents for critical limb ischemia: midterm angiographic and clinical results. J Vasc Interv Radiol. 2007;18:1351–61.

    Article  PubMed  Google Scholar 

  25. Siablis D, Karnabatidis D, Katsanos K, Diamantopoulous A, Christeas N, Kagadis G. Infrapopliteal application of sirolimus-eluting versus bare metal stents for critical limbs ischemia: analysis of long-term angiographic and clinical outcomes. J Vasc Interv Radiol. 2009;20:1141–50.

    Article  PubMed  Google Scholar 

  26. Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG, Rutherford RB et al. Inter-society consensus for the management of peripheral arterial disease (TASC II). J Vasc Surg. 2007; 45(Suppl S):9aTASC II.

    Google Scholar 

  27. Biondi-Zoccai GGL, Sangiorgi G, Lotrione M, Feiring A, Commeau P, Fusaro M, et al. Infragenicular stent implantation for below-the-knee atherosclerotic disease: clinical evidence from an international collaborative meta-analysis on 640 patients. J Endovasc Ther. 2009;18:251–60.

    Article  Google Scholar 

  28. Scheinert D. Achilles study–randomized comparison of Sirolimus eluting stents vs PTA for BTK obstructions. LINC 2011. http://www.leipzig-interventionalcourse.com/index.php?option=com_content&task=view&id=147&Itemid=248.

  29. Bosiers M, Scheinert D, Peeters P, Torsello G, Zeller T, Deloose K, et al. Randomized comparison of everolimus-eluting versus bare-metal stents in patients with critical limb ischemia and infrapopliteal arterial occlusive disease. J Vasc Surg. 2012;55:390–9.

    Article  PubMed  Google Scholar 

  30. Rastan A, Tepe G, Krakenberg H, Zahorsky R, Beschorner U, Noory E, et al. Sirolimus-eluting stents vs. bare-metal stents for treatment of focal lesions in infrapopliteal arteries: a double-blind, multi-centre randomized clinical trial. Eur Heart J. 2011;32:2274–81.

    Article  PubMed  CAS  Google Scholar 

  31. Chakavarty T, Whit AJ, Buch M, Naik H, Doctor N, Schapira J, et al. Meta-analysis of incidence, clinical characteristics and implications of stent fracture. Am J Cardiol. 2010;106(8):1075–80.

    Article  Google Scholar 

  32. Karnabatidis D, Katsanos K, Spiliopoulous S, Diamantopoulous A, Kagadis GC, Siablis D. Incidence, anatomical location, and clinical significance of compressions and fractures in infrapopliteal balloon-expandable metal stents. J Endovasc Ther. 2009;16:15–22.

    Article  PubMed  Google Scholar 

  33. Serruys PW, de Bruyne B, Carlier S, Sousa JE, Piek J, Muramatsu T, et al. Randomized comparison of primary stenting and provisional balloon angioplasty guided by flow velocity measurement; on behalf of the Doppler Endpoints Balloon Angioplasty Trial Europe (DEBATE) II Study Group. Circulation. 2000;102:2930–7.

    Article  PubMed  CAS  Google Scholar 

  34. Romiti M, Albers M, Brochado-Neto BC, Durazzo AES, Pereira CAB, De Luccia N. Meta-analysis of infrapopliteal angioplasty for chronic critical limb ischemia. J Vasc Surg. 2008;47:975–81.

    Article  PubMed  Google Scholar 

  35. Mauri L, O’Malley AJ, Popma JJ, et al. Comparison of thrombosis and restenosis risk from stent length of sirolimus-eluting stents versus bare metal stents. Am J Cardiol. 2005;95:1140–5.

    Article  PubMed  CAS  Google Scholar 

  36. Colmenarez HJ, Escaned J, Ferna´ndez C, Lobo L, Cano S, del Angel JG, et al. Efficacy and safety of drug-eluting stents in chronic total coronary occlusion recanalization a systematic review and meta-analysis. J Am Coll Cardiol. 2010;55:1854–66.

    Article  PubMed  CAS  Google Scholar 

  37. Holmes DR, Kereiakes DJ, Garg S, Serruys PW, Dehmer GJ, Ellis SG, et al. Stent thrombosis. J Am Coll Cardiol. 2010;56:1357–65.

    Article  PubMed  Google Scholar 

  38. Laird J, Zeller T, Gray BH, Scheinert D, Vranic M, Reiser C, et al. Limb salvage following laser-assisted angioplasty for critical limb ischemia: results of the LACI multicenter trial. J Endovasc Ther. 2006;13:1–11.

    Article  PubMed  Google Scholar 

  39. Bosiers M, Deloose K, Verbist J, Peeters P. Nitinol stenting for treatment of below-the-knee critical limb ischemia: 1-year angiographic outcome after Xpert stent implantation. J Cardiovasc Surg. 2007;48(4):455–61.

    CAS  Google Scholar 

  40. Bosiers M, Kallakuri S, Deloose K, Verbist J, Peeters P. Infragenicular angioplasty and stenting in the management of critical limb ischaemia: one year outcome following the use of the MULTI-LINK VISION stent. EuroIntervention. 2008;3:470–4.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Vascular Institute and Cardiac and Interventional Laboratory, Columbia-St. Marys Medical Center, 2350 North Lake Drive, Suite 303, Milwaukee, WI, 53211, USA

    Andrew J. Feiring MD

Authors
  1. Andrew J. Feiring MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Edward Hines, Jr. VA Hospital Loyola University Medical Center, Glen Ellyn, Illinois, USA

    Robert S. Dieter

  2. Northern Illinois Surgery Center, Naperville, Illinois, USA

    Raymond A. Dieter, Jr.

  3. University of Tennessee Medical Center, Knoxville, Tennessee, USA

    Raymond A. Dieter, III

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer Science+Business Media New York

About this chapter

Cite this chapter

Feiring, A.J. (2014). Drug-Eluting Stents (DES) for Infrapopliteal Interventions. In: Dieter, R., Dieter, Jr., R., Dieter, III, R. (eds) Endovascular Interventions. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-7312-1_63

Download citation

  • DOI: https://doi.org/10.1007/978-1-4614-7312-1_63

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4614-7311-4

  • Online ISBN: 978-1-4614-7312-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation